News
Ten companies posted a sluggish performance last week, with investor sentiment weighed down by a wave of negative ...
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
Barclays analyst Julian Mitchell raised the firm’s price target on GE Vernova, Inc. (NYSE: GEV) to $500 from $427 on May 30, ...
Gordon Johnson, an analyst at GLJ Research, downgraded United States Steel Corporation (NYSE:X) from Buy to Sell on May 30, ...
Actuate Therapeutics, Inc. (NASDAQ:ACTU) has announced breakthrough results from its Phase 2 trial of elraglusib combined ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results